DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Amantadine Hydrochloride is a drug marketed by Actavis Elizabeth, Alembic Pharms Ltd, Bionpharma Inc, Heritage Pharma, Invagen Pharms, Lannett Co Inc, Novelgenix Theraps, Rubicon, Sandoz, Strides Pharma, Upsher Smith Labs, Watson Labs, Watson Labs Inc, Zydus Pharms, Akorn, Anda Repository, Cmp Pharma Inc, G And W Labs Inc, Pharm Assoc, Teva Pharms, Vintage, Wockhardt Bio Ag, and Jubilant Generics. and is included in thirty-one NDAs.
The generic ingredient in AMANTADINE HYDROCHLORIDE is amantadine hydrochloride. There are seven drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the amantadine hydrochloride profile page.
A generic version of AMANTADINE HYDROCHLORIDE was approved as amantadine hydrochloride by UPSHER SMITH LABS on August 5th, 1986.
Summary for AMANTADINE HYDROCHLORIDE
Recent Clinical Trials for AMANTADINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|All India Institute of Medical Sciences, Bhubaneswar||Phase 4|
|Indian Council of Medical Research||Phase 4|
|Copenhagen University Hospital, Hvidovre||Phase 3|